Emerging Evidence on Membrane Estrogen Receptors as Novel Therapeutic Targets for Central Nervous System Pathologies
International Journal of Molecular Sciences · 17.02.2023 · 24 (4) · 4043
DOI: 10.3390/ijms24044043 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.02.2023. Verfasst von Agnieszka Wnuk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neuropharmacology and Epigenetics, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna Street…. Hauptthemen laut MEDLINE: Receptors, Estrogen, Central Nervous System Diseases, Molecular Targeted Therapy. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Maj Institute of Pharmacology.
Abstract (Originalsprache)
Nuclear- and membrane-initiated estrogen signaling cooperate to orchestrate the pleiotropic effects of estrogens. Classical estrogen receptors (ERs) act transcriptionally and govern the vast majority of hormonal effects, whereas membrane ERs (mERs) enable acute modulation of estrogenic signaling and have recently been shown to exert strong neuroprotective capacity without the negative side effects associated with nuclear ER activity. In recent years, GPER1 was the most extensively characterized mER. Despite triggering neuroprotective effects, cognitive improvements, and vascular protective effects and maintaining metabolic homeostasis, GPER1 has become the subject of controversy, particularly due to its participation in tumorigenesis. This is why interest has recently turned toward non-GPER-dependent mERs, namely, mERα and mERβ. According to available data, non-GPER-dependent mERs elicit protective effects against brain damage, synaptic plasticity impairment, memory and cognitive dysfunctions, metabolic imbalance, and vascular insufficiency. We postulate that these properties are emerging platforms for designing new therapeutics that may be used in the treatment of stroke and neurodegenerative diseases. Since mERs have the ability to interfere with noncoding RNAs and to regulate the translational status of brain tissue by affecting histones, non-GPER-dependent mERs appear to be attractive targets for modern pharmacotherapy for nervous system diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neuropharmacology and Epigenetics, Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Sciences, Smetna Street 12, 31-343 Krakow, Poland.
ORCID-Profile: Agnieszka Wnuk, Bernadeta Angelika Pietrzak
Förderung
- Maj Institute of Pharmacology
Zitieren
APA
Wnuk, A., Przepiórska, K., Pietrzak, B. A., & Kajta, M. (2023). Emerging Evidence on Membrane Estrogen Receptors as Novel Therapeutic Targets for Central Nervous System Pathologies. International Journal of Molecular Sciences, 24(4), 4043. https://doi.org/10.3390/ijms24044043
Vancouver
Wnuk A, Przepiórska K, Pietrzak BA, Kajta M. Emerging Evidence on Membrane Estrogen Receptors as Novel Therapeutic Targets for Central Nervous System Pathologies. International Journal of Molecular Sciences. 2023;24(4):4043. doi:10.3390/ijms24044043
BibTeX
@article{Wnuk2023,
author = {Wnuk, Agnieszka and Przepiórska, Karolina and Pietrzak, Bernadeta Angelika and Kajta, Małgorzata},
title = {Emerging Evidence on Membrane Estrogen Receptors as Novel Therapeutic Targets for Central Nervous System Pathologies},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {4043},
doi = {10.3390/ijms24044043}
}
EUVIMED